Offer - Urjas Oil for just ₹ 1 X
Clonit is an allopathic medicine The correct dosage of Clonit depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Clonit is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Clonit safe for pregnant women?
Clonit may have some side effects during pregnancy. Pregnant women should discontinue the use of Clonit, and talk to their doctor, if they notice any discomfort.
Is the use of Clonit safe during breastfeeding?
Breastfeeding women can take Clonit as it bears very minor side effects for them.
What is the effect of Clonit on the Kidneys?
Clonit is not harmful for kidneys.
What is the effect of Clonit on the Liver?
Clonit does not damage the liver.
What is the effect of Clonit on the Heart?
Clonit is not harmful for the heart.
Clonit should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Clonit unless your doctor advises you to do so -
Is this Clonit habit forming or addictive?
Forming a habit of Clonit has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Clonit since it will not make you feel sleepy.
Is it safe?
Yes, but consume Clonit only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Clonit in mental disorders is not effective.
Interaction between Food and Clonit
There isn't any research available on the side effects of taking Clonit with food.
Interaction between Alcohol and Clonit
Due to lack of research, there is no information about the side effects of taking Clonit with alcohol.
Yes, Clonit might lighten skin because it causes skin atrophy (skin thinning) which reduces the darkness of the skin. However, Clonit is not approved for skin lightening and should not be used for this purpose because it can cause unpleasant side effects.
Yes, Clonit is safe to use, if applied in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as skin atrophy (skin thinning), burning or stinging sensation of the skin. If you experience above-mentioned side after using this drug then inform your doctor and follow his/her instructions.
Yes, Clonit may be used for contact dermatitis caused by poison ivy because it can provide relief from swelling, itching, and redness.
Clonit contains clobetasol which is presumed to work by promoting the induction of inhibitory proteins (lipocortins) in the body. Lipocortins prevents the release of arachidonic acid which causes synthesis and release of certain chemicals such as histamine, leukotrienes, and prostaglandins that causes inflammation. In this way Clonit prevents the skin inflammation which provides relief to the patient from rash, itching, and redness.
Yes, Clonit might cause dry skin in few cases only. However, the exact cause behind dry skin is unknown. If you are experiencing excessive dryness of skin after applying this drug then you are advised to use a skin moisturizer. Skin moisturizer should be applied only after 30 minutes of applying this drug so that the Clonit can be absorbed by the skin.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370